CD8A and neoplasm: The cumulative effects of these molecular signals promote DCs phagocytosis of tumor cells, thereby facilitating DCs processing of tumor-derived antigens and subsequent DC-mediated cross-presentation to CD8+ cytotoxic T lymphocytes to release or induce type I interferons.